In silico study of novel niclosamide derivatives, SARS-CoV-2 nonstructural proteins catalytic residue-targeting small molecules drug candidates-Reference-Cited by-同舟云学术

In silico study of novel niclosamide derivatives, SARS-CoV-2 nonstructural proteins catalytic residue-targeting small molecules drug candidates

Published:2023-05 Issue:5 Volume:16 Page:104654
ISSN:1878-5352
Container-title:Arabian Journal of Chemistry
language:en
Short-container-title:Arabian Journal of Chemistry

Author:

Lawal Bashir,Tsai Sheng-Kuang,Wu Alexander T.H.,Huang Hsu-Shan

Publisher

Elsevier BV

Subject

General Chemical Engineering,General Chemistry

Reference100 articles.

1. Favipiravir: a new and emerging antiviral option in COVID-19;Agrawal;Med. J. Armed Forces India,2020

2. Predicting chemically-induced skin reactions. Part I: QSAR models of skin sensitization and their application to identify potentially hazardous compounds;Alves;Toxicol. Appl. Pharmacol.,2015

3. P-glycoprotein inhibition for optimal drug delivery;Amin;Drug Target Insights,2013

4. Coronavirus main proteinase (3CL^pro) structure: basis for design of anti-SARS drugs;Anand;Science,2003

5. Utilization of quercetin flavonoid compounds in red onion (Allium cepa L.) as inhibitor of spike sars-CoV-2 protein against ACE2 receptors;Azmi;Biosaintifika: J. Biol. Biol. Edu.,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational screening of potential bromodomain-containing protein 2 inhibitors for blocking SARS-CoV-2 infection through pharmacophore modeling, molecular docking and molecular dynamics simulation;Arabian Journal of Chemistry;2024-01

2. Assessing the Potential Contribution of In Silico Studies in Discovering Drug Candidates That Interact with Various SARS-CoV-2 Receptors;International Journal of Molecular Sciences;2023-10-24